In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
no speaker photo
Speaker
Pardeep Jhund
Pardeep Jhund Pardeep Jhund

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

Specialities : Chronic Heart Failure , General Cardiology, Pharmacology and Pharmacotherapy

10 presentations from this speaker

Management of the heart failure patient with diabetes.

Event : Webinar 2019

  • Session : HFA Webinars 2019
  • Speaker : J Celutkiene (Vilnius,LT), H Drexel (Feldkirch,AT), P Jhund (Glasgow,GB)

What test of functional capacity?

Event : Heart Failure 2018

  • Session : Planning a new trial – What endpoints?
  • Speaker : P Jhund (Glasgow,GB)

Clinical assessment.

Event : Heart Failure 2017

  • Session : Essentials of congestion in acute heart failure
  • Speaker : P Jhund (Glasgow,GB)

Biomarkers and renal function.

Event : Heart Failure 2015

  • Session : Results of PARADIGM-HF: a closer look
  • Speaker : P Jhund (Glasgow,GB)

Effect of the angiotensin receptor neprilysin inhibitor LCZ696 compared with enalapril according to age in PARADIGM-HF

Event : Heart Failure 2015

  • Session : Moderated Poster Session 4 - Clinical management of chronic heart failure
  • Speaker : P Jhund (Glasgow,GB)

Severity of renal impairment in patients with heart failure and atrial fibrillation: implications for novel oral anticoagulant dose adjustment

Event : ESC Congress 2015

  • Session : Impact of the environment on anticoagulation in non-valvular atrial fibrillation
  • Speaker : P Jhund (Glasgow,GB)

High prevalence of elevated high sensitivity troponin-T and reduction in levels by LCZ696 in heart failure with preserved ejection fraction in the PARAMOUNT trial

Event : ESC Congress 2014

  • Session : Defining prognosis in heart failure with preserved ejection fraction
  • Speaker : P Jhund (Glasgow,GB)

Soluble ST2 is associated with markers of diastolic dysfunction in patients with heart failure with preserved ejection fraction in the PARAMOUNT trial.

Event : ESC Congress 2014

  • Session : Understanding heart failure with preserved ejection fraction
  • Speaker : P Jhund (Glasgow,GB)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are